Ulta Beauty (ULTA) Cuts FY24 View Despite Q1 Earnings Beat
https://www.zacks.com/stock/news/2282299/ulta-beauty-ulta-cuts-fy24-view-despite-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2282299
May 31, 2024 - Ulta Beauty's (ULTA) Q1 results reflect y/y comparable sales growth amid a dynamic operating landscape. Management lowers the earnings and sales view for FY24.
0
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
https://www.zacks.com/stock/news/2281925/pharma-stock-roundup-jnj-mrk-m-a-deals-sny-rhhby-drugs-priority-review-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2281925
May 31, 2024 - J&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority Review tags to Sanofi's (SNY) and Roche's (RHHBY) regulatory applications.
0
Kohl's (KSS) Cuts View on Q1 Earnings Miss, Low Comparable Sales
https://www.zacks.com/stock/news/2281420/kohl-s-kss-cuts-view-on-q1-earnings-miss-low-comparable-sales?cid=CS-ZC-FT-analyst_blog|earnings_article-2281420
May 30, 2024 - Kohl's (KSS) first-quarter fiscal 2024 results reflect soft comparable sales. Management curtails the 2024 view due to a drab Q1 and uncertainty in the consumer landscape.
0
Macy's (M) Embraces Transformation With A Bold New Chapter
https://www.zacks.com/stock/news/2280858/macy-s-m-embraces-transformation-with-a-bold-new-chapter?cid=CS-ZC-FT-analyst_blog|rank_focused-2280858
May 29, 2024 - Macy's (M) is transforming with its "A Bold New Chapter" strategy, modernizing operations, and leveraging AI to boost efficiency and ensure sustainable growth in the competitive retail sector.
0
Earnings Estimates Rising for Macy's (M): Will It Gain?
https://www.zacks.com/stock/news/2279657/earnings-estimates-rising-for-macy-s-m-will-it-gain?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2279657
May 27, 2024 - Macy's (M) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
Why Fast-paced Mover Macy's (M) Is a Great Choice for Value Investors
https://www.zacks.com/stock/news/2279294/why-fast-paced-mover-macy-s-m-is-a-great-choice-for-value-investors?cid=CS-ZC-FT-tale_of_the_tape|fast_paced_momentum_at_a_bargain-2279294
May 27, 2024 - Macy's (M) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
0
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
https://www.cnbc.com/2024/05/23/this-up-and-coming-cancer-treatment-could-be-a-25-billion-market-opportunity.html
May 23, 2024 - Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.
0
Company News for May 22, 2024
https://www.zacks.com/stock/news/2277171/company-news-for-may-22-2024?cid=CS-ZC-FT-corporate_summary-2277171
May 22, 2024 - Companies in The News Are:AZO,M,EXP,ZIM
0
Macy's (M) Q1 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/05/21/macys-m-q1-2024-earnings-call-transcript/?source=iedfolrf0000001
May 21, 2024 - M earnings call for the period ending March 31, 2024.
0
3 Reasons Growth Investors Will Love M/I Homes (MHO)
https://www.zacks.com/stock/news/2276850/3-reasons-growth-investors-will-love-m-i-homes-mho?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2276850
May 21, 2024 - M/I Homes (MHO) possesses solid growth attributes, which could help it handily outperform the market.
0